This Ex Parte Appeal was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on July 01, 2020 and assigned serial number 88660605 by the TTAB.

Plaintiff:
Alembic Pharmaceuticals, Inc. represented by ALBERT H MANWARING IV of MORRIS JAMES LLP.
Trademark Information: ALEMBIC PHARMACEUTICALS – US Trademark Serial Number 88660605
View Trademark Status at USPTO
View Trademark Documents at USPTO

********

Prosecution History:
July 01, 2020 – APPEAL TO BOARD
July 01, 2020 – APPEAL ACKNOWLEDGED; CASE REMANDED
July 01, 2020 – INSTITUTED
January 06, 2021 – RECON DENIED
January 26, 2021 – PROCEEDINGS RESUMED
March 25, 2021 – APPEAL BRIEF
March 26, 2021 – APPEAL FORWARDED TO EXAMINER FOR BRIEF
May 17, 2021 – JURISDICTION RESTORED/REMANDED TO EXAMINER
June 17, 2021 – RECON DENIED
June 21, 2021 – PROCEEDINGS RESUMED
June 22, 2021 – CORRECTION TO BD ORDER
September 08, 2021 – APPEAL FORWARDED TO EXAMINER FOR BRIEF
October 27, 2021 – EXAMINER’S REQ FOR REMAND
November 02, 2021 – JURISDICTION RESTORED/REMANDED TO EXAMINER
December 08, 2021 – RECON DENIED
January 21, 2022 – PROCEEDINGS RESUMED
March 22, 2022 – SUPPLEMENTAL BRIEF
March 28, 2022 – APPEAL FORWARDED TO EXAMINER FOR BRIEF
May 26, 2022 – EXAMINER’S BRIEF
June 14, 2022 – REPLY BRIEF
June 29, 2022 – MEMO FORWARDING REPLY BRIEF
June 29, 2022 – SUBMITTED FOR FINAL DECISION
September 13, 2022 – FINAL DECISION: AFFIRMED
November 28, 2022 – TERMINATED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.